A detailed history of Td Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Td Capital Management LLC holds 54 shares of ABBV stock, worth $9,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54
Previous 54 -0.0%
Holding current value
$9,720
Previous $9,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $159 - $182
1 Added 1.89%
54 $9,000
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $46,784 - $52,689
-340 Reduced 86.51%
53 $8,000
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $534 - $618
4 Added 1.03%
393 $58,000
Q2 2023

Aug 16, 2023

BUY
$132.51 - $164.9 $397 - $494
3 Added 0.78%
389 $52,000
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $3,036 - $3,497
-21 Reduced 5.16%
386 $61,000
Q4 2022

Feb 15, 2023

BUY
$138.31 - $165.87 $4,010 - $4,810
29 Added 7.67%
407 $65,000
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $50,731 - $58,185
378 New
378 $51,000
Q1 2022

May 18, 2022

SELL
$131.98 - $163.75 $57,939 - $71,886
-439 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $11,387 - $14,408
-106 Reduced 19.45%
439 $59,000
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $425 - $483
4 Added 0.74%
545 $59,000
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $526 - $586
5 Added 0.93%
541 $61,000
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $12,889 - $14,190
126 Added 30.73%
536 $58,000
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $402 - $543
5 Added 1.23%
410 $44,000
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $34,793 - $40,836
405 New
405 $35,000
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $28,655 - $34,452
-455 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$65.7 - $83.98 $29,893 - $38,210
455 New
455 $33,000
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $10,030 - $10,999
-112 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $7,823 - $9,992
112
112 $10,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Td Capital Management LLC Portfolio

Follow Td Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Capital Management LLC with notifications on news.